← Open Payments lookup

VESELA TZONEVA-KAMBEROVA: Open Payments

NPI 1356436794 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$405 in 19 payments from 8 companies in 2025. Trend: 2023 $143 · 2024 $169 · 2025 $405

Food & beverage: $405
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$121
Neurocrine BioSciences, Inc.4$82
Alkermes, Inc.2$48
Otsuka America Pharmaceutical, Inc.2$44
Ethicon US, LLC1$40
Janssen Pharmaceuticals, Inc2$39
E.R. Squibb & Sons, L.L.C.1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$15

Products named: AUSTEDO XR, INGREZZA, ARISTADA, VISTASEAL, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, COBENFY.

Industry payments across LA — which companies pay providers there.